Clinical Efficacy

Preliminary evidence suggests short-term cognitive and mood improvements in Alzheimer's patients receiving TPS. Reported TPS effects extend beyond Alzheimer's disease to several neurological and psychiatric conditions. Validated scales will be used to measure cognitive outcomes and condition-specific psychometric outcomes.